Search
News Archive
Categories
Aurora Algae Raises $22 Million in Funding Round
Posted On: September 4, 2011Aurora Algae, with dual operations in Hayward, CA and Karratha, Australia, has received a round of $22 million from Oak Investment Partners, other existing investors, and a large foreign strategic investor who, at this time, has not been identified.
The funding will help Aurora execute plans for the construction of its commercial facility in Maitland, Western Australia — for which the company secured 610 hectares (approximately 1500 acres) of land earlier this year — and expand operations within its Hayward (CA) and Karratha (Western Australia) facilities. They expect to break ground in Maitland early next year.
Marine-tech: A New Wave of Ventures for InLab in California
Posted On: April 15, 2010InLab’s regional focus spans the coastline from San Diego, to Los Angeles and the Bay Area to Seattle. As a result, Inlab Ventures has decided to form a new sector of ventures that we will pursue for our portfolio: marine ventures. This will include technology applications in the areas of port and intercoastal security, anti-terrorism and anti-piracy, drug enforcement, marine biotech, desalination and water supply technologies, navigation and tracking systems, and marine energy.
With Inlab’s proximity to world-class universities such as Scripps and other California universities with research programs in marine science, as well as some of the largest ports in the country, it makes perfect sense to leverage the resources in this region. InLab has connections with the U.S. Coast Guard, the local port authorities, the National Science Foundation, and the Department of Homeland Security.
Algal Biomass Organization Announces Algae Finance Summit in NY
Posted On: April 15, 2010The Algal Biomass Organization (ABO), the leading trade association for the algae industry, today announced it will be hosting an Algae Finance Summit on May 13th, 2010 at New York City’s Flatotel. The day-long event will provide investors, analysts and fund managers with the information needed to make informed investment decisions and recommendations regarding opportunities in the fast-developing algae for energy industry.
Key experts, including government regulators and policymakers, algae producers, legal experts and investment professionals, will offer attendees a holistic — and realistic — assessment of the capital needs and financing structures for algae companies and projects, as well as the role of the federal government in regulating the industry and facilitating its growth through funding.
Aquapharm completes £4.2 million investment
Posted On: March 23, 2010Aquapharm Biodiscovery, a leading marine biotechnology company based at the European Centre for Marine Biotechnology in Oban, Scotland, today announces the close of a £4.2 million investment from existing investors Aescap Venture, Tate & Lyle Ventures, Highlands and Islands Enterprise and NESTA. Alongside the completion of the financing, Aquapharm has appointed the seasoned biotech entrepreneur Simon Best as CEO. Current CEO and founder Andrew Mearns Spragg will take up the role of Chief Technical Officer.
The additional finance will be used towards the further development and commercialisation of Aquapharm’s product portfolio produced from over 7,250 marine micro-organisms. Natural products from this unique source of new biological and chemical diversity are already being exploited commercially with major partners such as Croda Plc and Dr Reddy’s Laboratories in the personal care and pharmaceutical fields respectively. New collaborations in further applications such as nutrition are also in the pipeline.
Host
 |
Partners
  |
Sponsors
 |
 |
Share Aquapreneur
